Category:Hematology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Hudakarman (talk | contribs) |
||
| Line 27: | Line 27: | ||
* Transfusion reactions (SP) | * Transfusion reactions (SP) | ||
* Myeloproliferative neoplasms (LP) | * Myeloproliferative neoplasms (LP) | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Category}} | |||
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Chapters that need content}} | |||
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Assignment Status}} | |||
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Scholar's name}} | |||
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Coach name}} | |||
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Completion Status}} | |||
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Review status}} | |||
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Reviewer name}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="21" |Hematology | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Alpha thalassemia | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
Insert paragraph | |||
* Microangiopathic hemolytic anemia | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Myelophthisic anemia | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* | |||
* Glucose-6-phosphate dehydrogenase deficiency | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* | |||
* Pupura (LP) | |||
** Papular (SP) | |||
** Infectious (SP) | |||
** Purpura fulminans | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
** | |||
** | |||
** | |||
* Thrombotic micropangiopathies (LP) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* opangiopathies (LP) | |||
* Hemophilia (LP)(Muhammad)(Abdelrahman) | |||
** Hemophilia A | |||
** Hemophilia B | |||
* Neutrophilia (SP) | |||
* Neutropenia (SP) | |||
* Lymphocytosis (SP) | |||
* Monocytosis (SP) | |||
* Eosiniphilia (SP) | |||
* Basophilia (SP) | |||
* Lymphadenopathy (SP) | |||
* Transfusion therapy (SP) | |||
* Transfusion reactions (SP) | |||
* Myeloproliferative neoplasms (LP) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|} | |||
==In progress chapters== | |||
==Completed chapters== | |||
Revision as of 17:15, 18 June 2020
List of Chapters Requiring Content
- Alpha thalassemia
- Microangiopathic hemolytic anemia
- Myelophthisic anemia
- Glucose-6-phosphate dehydrogenase deficiency
- Pupura (LP)
- Papular (SP)
- Infectious (SP)
- Purpura fulminans
- Thrombotic micropangiopathies (LP)
- Hemophilia (LP)
- Hemophilia A
- Hemophilia B
- Neutrophilia (SP)
- Neutropenia (SP)
- Lymphocytosis (SP)
- Monocytosis (SP)
- Eosiniphilia (SP)
- Basophilia (SP)
- Lymphadenopathy (SP)
- Transfusion therapy (SP)
- Transfusion reactions (SP)
- Myeloproliferative neoplasms (LP)
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Hematology |
|
||||||
|
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
In progress chapters
Completed chapters
Subcategories
This category has the following 6 subcategories, out of 6 total.
Pages in category "Hematology"
The following 200 pages are in this category, out of 4,403 total.
(previous page) (next page)2
- 22q11.2 deletion syndrome causes
- 22q11.2 deletion syndrome chest x ray
- 22q11.2 deletion syndrome CT
- 22q11.2 deletion syndrome echocardiography
- 22q11.2 deletion syndrome electrocardiogram
- 22q11.2 deletion syndrome epidemiology and demographics
- 22q11.2 deletion syndrome history and symptoms
- 22q11.2 deletion syndrome laboratory findings
- 22q11.2 deletion syndrome medical therapy
- 22q11.2 deletion syndrome MRI
- 22q11.2 deletion syndrome other diagnostic studies
- 22q11.2 deletion syndrome other imaging findings
- 22q11.2 deletion syndrome overview
- 22q11.2 deletion syndrome pathophysiology
- 22q11.2 deletion syndrome physical examination
- 22q11.2 deletion syndrome primary prevention
- 22q11.2 deletion syndrome risk factors
- 22q11.2 deletion syndrome screening
- 22q11.2 deletion syndrome secondary prevention
- 22q11.2 deletion syndrome surgery
A
- Abdominal mass
- Abdominal mass (patient information)
- Abdominal mass case study one
- Abdominal mass causes
- Abdominal mass cost-effectiveness of therapy
- Abdominal mass CT
- Abdominal mass differential diagnosis
- Abdominal mass epidemiology and demographics
- Abdominal mass future or investigational therapies
- Abdominal mass history and symptoms
- Abdominal mass laboratory findings
- Abdominal mass medical therapy
- Abdominal mass MRI
- Abdominal mass natural history, complications and prognosis
- Abdominal mass other diagnostic studies
- Abdominal mass other imaging findings
- Abdominal mass overview
- Abdominal mass pathophysiology
- Abdominal mass physical examination
- Abdominal mass primary prevention
- Abdominal mass risk factors
- Abdominal mass secondary prevention
- Abdominal mass surgery
- Abdominal mass ultrasound
- Abdominal mass x ray
- Abnormalities in erythrocyte morphology
- ABO incompatibility (patient information)
- Absolute neutrophil count
- Acanthocytosis
- Acanthocytosis (patient information)
- Acanthocytosis case study one
- Acanthocytosis causes
- Acanthocytosis cost-effectiveness of therapy
- Acanthocytosis CT
- Acanthocytosis differential diagnosis
- Acanthocytosis epidemiology and demographics
- Acanthocytosis future or investigational therapies
- Acanthocytosis history and symptoms
- Acanthocytosis laboratory findings
- Acanthocytosis medical therapy
- Acanthocytosis MRI
- Acanthocytosis natural history, complications and prognosis
- Acanthocytosis other diagnostic studies
- Acanthocytosis other imaging findings
- Acanthocytosis overview
- Acanthocytosis pathophysiology
- Acanthocytosis physical examination
- Acanthocytosis prevention
- Acanthocytosis risk factors
- Acanthocytosis surgery
- Acquired disorders of the bone marrow
- Acquired hemolytic anemia
- Acral dysostosis - dyserythropoiesis
- Acral necrosis
- Activated clotting time
- Activated protein C resistance
- ACUITY HORIZONS bleeding criteria
- Acute basophilic leukemia
- Acute chest syndrome
- Acute chest syndrome case study one
- Acute chest syndrome causes
- Acute chest syndrome chest x ray
- Acute chest syndrome cost-effectiveness of therapy
- Acute chest syndrome CT
- Acute chest syndrome differential diagnosis
- Acute chest syndrome echocardiography or ultrasound
- Acute chest syndrome electrocardiogram
- Acute chest syndrome epidemiology and demographics
- Acute chest syndrome future or investigational therapies
- Acute chest syndrome historical perspective
- Acute chest syndrome history and symptoms
- Acute chest syndrome laboratory findings
- Acute chest syndrome medical therapy
- Acute chest syndrome MRI
- Acute chest syndrome natural history, complications and prognosis
- Acute chest syndrome other diagnostic studies
- Acute chest syndrome other imaging findings
- Acute chest syndrome overview
- Acute chest syndrome pathophysiology
- Acute chest syndrome physical examination
- Acute chest syndrome prevention
- Acute chest syndrome risk factors
- Acute chest syndrome screening
- Acute chest syndrome surgery
- Acute eosinophilic leukemia
- Acute lymphoblastic leukemia
- Acute lymphoblastic leukemia case study one
- Acute lymphoblastic leukemia chest x ray
- Acute lymphoblastic leukemia classification
- Acute lymphoblastic leukemia cost-effectiveness of therapy
- Acute lymphoblastic leukemia CT
- Acute lymphoblastic leukemia diagnostic study of choice
- Acute lymphoblastic leukemia differential diagnosis
- Acute lymphoblastic leukemia echocardiography and ultrasound
- Acute lymphoblastic leukemia electrocardiogram
- Acute lymphoblastic leukemia epidemiology and demographics
- Acute lymphoblastic leukemia future or investigational therapies
- Acute lymphoblastic leukemia historical perspective
- Acute lymphoblastic leukemia history and symptoms
- Acute lymphoblastic leukemia laboratory findings
- Acute lymphoblastic leukemia medical therapy
- Acute lymphoblastic leukemia MRI
- Acute lymphoblastic leukemia natural history, complications and prognosis
- Acute lymphoblastic leukemia other diagnostic studies
- Acute lymphoblastic leukemia other imaging findings
- Acute lymphoblastic leukemia overview
- Acute lymphoblastic leukemia pathophysiology
- Acute lymphoblastic leukemia physical examination
- Acute lymphoblastic leukemia primary prevention
- Acute lymphoblastic leukemia risk factors
- Acute lymphoblastic leukemia screening
- Acute lymphoblastic leukemia secondary prevention
- Acute lymphoblastic leukemia x ray
- Acute Lymphocytic Leukemia
- Acute megakaryoblastic leukemia
- Acute megakaryoblastic leukemia case study one
- Acute megakaryoblastic leukemia classification
- Acute megakaryoblastic leukemia cost-effectiveness of therapy
- Acute megakaryoblastic leukemia differential diagnosis
- Acute megakaryoblastic leukemia epidemiology and demographics
- Acute megakaryoblastic leukemia future or investigational therapies
- Acute megakaryoblastic leukemia history and symptoms
- Acute megakaryoblastic leukemia laboratory findings
- Acute megakaryoblastic leukemia medical therapy
- Acute megakaryoblastic leukemia natural history, complications and prognosis
- Acute megakaryoblastic leukemia other diagnostic studies
- Acute megakaryoblastic leukemia overview
- Acute megakaryoblastic leukemia pathophysiology
- Acute megakaryoblastic leukemia physical examination
- Acute megakaryoblastic leukemia surgery
- Acute monocytic leukemia case study one
- Acute monocytic leukemia causes
- Acute monocytic leukemia classification
- Acute monocytic leukemia cost-effectiveness of therapy
- Acute monocytic leukemia criteria
- Acute monocytic leukemia differential diagnosis
- Acute monocytic leukemia epidemiology and demographics
- Acute monocytic leukemia future or investigational therapies
- Acute monocytic leukemia historical perspective
- Acute monocytic leukemia history and symptoms
- Acute monocytic leukemia laboratory findings
- Acute monocytic leukemia medical therapy
- Acute monocytic leukemia natural history, complications and prognosis
- Acute monocytic leukemia other diagnostic studies
- Acute monocytic leukemia overview
- Acute monocytic leukemia pathophysiology
- Acute monocytic leukemia physical examination
- Acute monocytic leukemia prevention
- Acute monocytic leukemia risk factors
- Acute monocytic leukemia screening
- Acute monocytic leukemia surgery
- Acute myeloblastic leukemia (patient information)
- Acute myeloblastic leukemia causes
- Acute myeloblastic leukemia chest x ray
- Acute myeloblastic leukemia classification
- Acute myeloblastic leukemia cost-effectiveness of therapy
- Acute myeloblastic leukemia CT
- Acute myeloblastic leukemia differential diagnosis
- Acute myeloblastic leukemia epidemiology and demographics
- Acute myeloblastic leukemia future or investigational therapies
- Acute myeloblastic leukemia historical perspective
- Acute myeloblastic leukemia history and symptoms
- Acute myeloblastic leukemia laboratory tests
- Acute myeloblastic leukemia medical therapy
- Acute myeloblastic leukemia MRI
- Acute myeloblastic leukemia natural history
- Acute myeloblastic leukemia other diagnostic studies
- Acute myeloblastic leukemia overview
- Acute myeloblastic leukemia pathophysiology
- Acute myeloblastic leukemia physical examination
- Acute myeloblastic leukemia primary prevention
- Acute myeloblastic leukemia risk factors
- Acute myeloblastic leukemia screening
- Acute myeloblastic leukemia secondary prevention
- Acute myeloblastic leukemia surgery
- Acute myeloblastic leukemia with maturation
- Acute Myelogenous Leukemia
- Acute myeloid leukemia
- Acute myeloid leukemia (patient information)